Clinical Trial Update: Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients . [Phase 2]

View source ↗

Summary

A phase 2 clinical trial evaluating radiotherapy in combination with camrelizumab and apatinib for hepatocellular carcinoma; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: Beijing Tsinghua Chang Gung Hospital | Conditions: Liver Cancer | Phase 2 | Status: NOT_YET_RECRUITING